[SYRE] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
28-Sep-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 18.32%
YoY- 10.21%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 688 198 168 174 625 1,362 3,644 -67.18%
PBT -217,074 -18,458 -18,784 -18,443 -22,314 -24,436 -20,423 385.51%
Tax 7 -36 38 -209 9 0 23 -54.85%
NP -217,081 -18,422 -18,822 -18,234 -22,323 -24,436 -20,446 385.16%
Tax Rate - - - - - - - -
Total Cost 217,769 18,620 18,990 18,408 22,948 25,798 24,090 335.70%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -31,552.47 -9,304.04 -11,203.57 -10,479.31 -3,571.68 -1,794.13 -561.09 1378.67%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -56.79 -4.89 -7.20 -4.84 -6.79 -9.26 -10.36 211.86%
EPS Diluted -56.79 -4.89 -7.20 -4.84 -6.79 -9.26 -10.36 211.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.